Year: 2026
Type: article
Abstract: Precision oncology is revolutionizing cancer care, but isn't reaching enough patients. Molecular tumor boards (MTBs) translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost clinical outcomes. But how can we feasibly and equitably expand the use of MTBs?
Source: PLoS Medicine
Authors: Margaret M. Byrne, Jill M. Kolesar
Institution: University of Iowa
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,460
OpenAlex ID: W7166644788